Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07377747 · ClinicalTrials.gov registry record
Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma
A clinical trial of Retroperitoneal Liposarcoma, sponsored by Australia and New Zealand Sarcoma Association.
- Recruiting
- Registry status
- 100
- Enrollment target
- 9
- Study locations
NCT07377747: Recruiting study of Retroperitoneal Liposarcoma, sponsored by Australia and New Zealand Sarcoma Association.
NCT07377747 is a study of Retroperitoneal Liposarcoma that is actively recruiting participants, run by Australia and New Zealand Sarcoma Association. The registered enrollment target is 100 participants. The trial reports 9 study locations across 8 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07377747, a study of Retroperitoneal Liposarcoma, is actively recruiting participants, sponsored by Australia and New Zealand Sarcoma Association.
- RECRUITING
- Registry status
- 100 participants
- Enrollment target
- 9
- Study locations
Study Summary
The aim of the study is to collect prospective data on the treatment outcomes in patients with first localized, resectable recurrent retroperitoneal well-differentiated and/or dedifferentiated liposarcoma undergoing curative intent treatment. Patients enrolled in this study will form a validation cohort of the TARPSWG recurrent RPS nomogram. The treatment decision (surgery alone, or preoperative RT +/- chemotherapy followed by surgery) is per the institutional multidisciplinary team recommendation.
Primary Outcome
Defined as the time from the date of treatment start (either surgery, chemo or RT) for 1st recurrent LPS to the date of radiological abdominopelvic relapse or death whichever occurred first. Liver metastases will be regarded as distant metastatic events. rather than abdominopelvic relapse
Conditions Studied
Study Locations (9)
New South Wales
- Chris O'Brien Lifehouse - Camperdown
- Prince of Wales Hospital - Randwick
Georgia
- Emory Winship Cancer Institute - Atlanta
Ohio
- OSU James Hospital - Columbus
Texas
- MD Anderson Cancer Center - Houston
Victoria
- Peter MacCallum Cancer Centre - Melbourne
Flemish Brabant
- UZ Leuven - Leuven
São Paulo
- A.C.Camargo Cancer Center - Fundacao Antonio Prudente - Liberdade
North Holland
- The Netherlands Cancer Institute - Amsterdam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2024-09-05 |
| Est. Completion | 2032-12 |
What NCT07377747 shows while recruiting
NCT07377747 is an observational study that tracks outcomes without assigning an intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap.
The record links to 1 condition, with Retroperitoneal Liposarcoma appearing as the primary indexed condition, and to 0 interventions.
NCT07377747 lists 9 locations in 8 states (New South Wales, Georgia, Ohio).
Frequently Asked Questions
What is clinical trial NCT07377747 about?
NCT07377747 is a clinical study titled "Prospective Study Evaluating the Treatment Outcomes for Localised Recurrent, Resectable Retroperitoneal Liposarcoma". The aim of the study is to collect prospective data on the treatment outcomes in patients with first localized, resectable recurrent retroperitoneal well-differentiated and/or dedifferentiated liposarcoma undergoing curative intent treatment. Patients enrolled in this study will form a validation co...
What is the current status of trial NCT07377747?
This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2024-09-05. Estimated completion is 2032-12.
What conditions does trial NCT07377747 study?
This clinical trial studies the following conditions: Retroperitoneal Liposarcoma.
Who is sponsoring clinical trial NCT07377747?
This trial is sponsored by Australia and New Zealand Sarcoma Association, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07377747 being conducted?
This trial has 9 study locations across Georgia, Ohio, Texas, New South Wales, Victoria. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Retroperitoneal Liposarcoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI